Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Airgain | AIRG | Nov 27, 2024 | 8.79 | -2.22 |
AirJoule Technologies A | AIRJ | Nov 27, 2024 | 7.92 | -3.53 |
AirNet Technology ADR | ANTE | Nov 27, 2024 | 0.44 | -6.89 |
AirSculpt Technologies | AIRS | Nov 27, 2024 | 6.63 | +1.14 |
Airship AI A | AISP | Nov 27, 2024 | 2.60 | +2.77 |
AIX ADR | AIFU | Nov 27, 2024 | 1.35 | 0.00 |
Akamai Technologies | AKAM | Nov 27, 2024 | 93.86 | +0.82 |
Akanda | AKAN | Nov 27, 2024 | 1.70 | +4.94 |
Akari Therapeutics ADR | AKTX | Nov 27, 2024 | 1.12 | -1.75 |
Akebia Therapeutics | AKBA | Nov 27, 2024 | 2.06 | +0.49 |
Akero Therapeutics | AKRO | Nov 27, 2024 | 32.17 | +3.24 |
Akoustis Technologies | AKTS | Nov 27, 2024 | 0.11 | +12.24 |
Akoya BioSciences | AKYA | Nov 27, 2024 | 2.14 | -2.73 |
Akso Health ADR | AHG | Nov 27, 2024 | 0.80 | -6.47 |
Alamo Group | ALG | Nov 27, 2024 | 197.89 | +0.07 |
Alamos Gold | AGI | Nov 27, 2024 | 18.45 | +0.38 |
Alarm.com | ALRM | Nov 27, 2024 | 64.17 | -0.56 |
Alarum Technologies ADR | ALAR | Nov 27, 2024 | 12.95 | -3.57 |
Alaska Air Group | ALK | Nov 27, 2024 | 52.68 | -0.47 |
Alaunos Therapeutics | TCRT | Nov 27, 2024 | 2.81 | +20.60 |
Albany International | AIN | Nov 27, 2024 | 82.40 | -0.81 |
Albemarle | ALB | Nov 27, 2024 | 107.98 | +1.11 |
Albemarle ADR A Pref | ALB-A | Nov 27, 2024 | 48.43 | -0.45 |
Albertsons Companies A | ACI | Nov 27, 2024 | 19.62 | +0.41 |
Alchemy Investments Acquisition 1 | ALCY | Nov 27, 2024 | 11.11 | +0.09 |
Alchemy Investments Acquisition 1 Units | ALCYU | Nov 27, 2024 | 11.01 | 0.00 |
Alcoa | AA | Nov 27, 2024 | 45.88 | -3.25 |
Alcon | ALC | Nov 27, 2024 | 88.23 | +1.13 |
Aldel Financial II | ALDFU | Nov 27, 2024 | 9.99 | 0.00 |
Aldeyra Therapeutics | ALDX | Nov 27, 2024 | 4.94 | +2.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.